1. Masters - Business Administration [London Business School, University of London (United Kingdom)]
2. Degree - Bachelor of Medicine and Bachelor of Surgery [Royal Free Hospital School of Medicine, University of London (currently known as University College London Medical School) (United Kingdom)]
Working Experience
Dr Chong Su-Lin began her career in 1984 as a medical practitioner in the National Health Service in United Kingdom. She was the CEO of Sunway Medical Centre, CEO of Prince Court Medical Centre, and Executive Director of Beacon Specialist Hospital as well as CEO of the Healthcare arm of the International Medical University. Dr Chong was the "Lab" leader for the healthcare National Key Economic Areas blueprint planning by the Malaysia Government in 2010, and more recently a member of the task force appointed by the Minister of Health to look into workplace culture in the Ministry of Health hospitals. Dr Chong is currently an Independent Non-Executive Director ("INED") of Cengild Medical Berhad since 2021. She is also the Chairman of the Risk Management Committee, a Member of the Audit Committee, Remuneration Committee, Nominating Committee as well as Long Term Incentive Plan Committee. Dr Chong Su-Lin is also an INED and Chairman of the Board Nomination Committee of AIA Berhad. She is also a Council Member of Hospis Malaysia as well as INED of ECRI Berhad and Director of Naluri Hidup Sdn Bhd.
Directorship of Public Companies
1. Cengild Medical Berhad 2. AIA Berhad 3. Hospis Malaysia 4. ECRI Berhad
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
MQ Trader 256 views | 1 d ago
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
MQ Trader 11346 views | 9 d ago
0:17
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....